First-in-class ruthenium anticancer drug (KP1339/IT-139) induces an immunogenic cell death signature in colorectal spheroids in vitro
- Author(s)
- Debora Wernitznig, Konstantinos Kiakos, Giorgia Del Favero, Nathalie Harrer, Herwig Machat, Annika Osswald, Michael A. Jakupec, Andreas Wernitznig, Wolfgang Sommergruber, Bernhard K. Keppler
- Organisation(s)
- Department of Inorganic Chemistry, Department of Food Chemistry and Toxicology
- External organisation(s)
- Boehringer Ingelheim Austria, Research Cluster Translational Cancer Therapy Research
- Journal
- Metallomics: integrated biometal science
- Volume
- 11
- Pages
- 1044-1048
- No. of pages
- 5
- ISSN
- 1756-5901
- DOI
- https://doi.org/10.1039/c9mt00051h
- Publication date
- 06-2019
- Peer reviewed
- Yes
- Austrian Fields of Science 2012
- 104003 Inorganic chemistry, 301904 Cancer research, 106023 Molecular biology
- Keywords
- ASJC Scopus subject areas
- Metals and Alloys, Chemistry (miscellaneous), Biophysics, Biochemistry, Biomaterials
- Sustainable Development Goals
- SDG 3 - Good Health and Well-being
- Portal url
- https://ucrisportal.univie.ac.at/en/publications/e5110f11-9113-4cc9-8f5d-4154adc19ac5